These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1282452)

  • 1. Effect of a prostaglandin I2 derivative (iloprost) on peripheral neuropathy of diabetic rats.
    Ohno A; Kanazawa A; Tanaka A; Miwa T; Ito H
    Diabetes Res Clin Pract; 1992 Nov; 18(2):123-30. PubMed ID: 1282452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic adenosine 3',5'-monophosphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats.
    Shindo H; Tawata M; Onaya T
    Endocrinology; 1993 Feb; 132(2):510-6. PubMed ID: 7678791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats.
    Sonobe M; Yasuda H; Hisanaga T; Maeda K; Yamashita M; Kawabata T; Kikkawa R; Taniguchi Y; Shigeta Y
    Diabetes; 1991 Jun; 40(6):726-30. PubMed ID: 1645681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.
    Naka K; Sasaki H; Kishi Y; Furuta M; Sanke T; Nanjo K; Mukoyama M
    Diabetes Res Clin Pract; 1995 Dec; 30(3):153-62. PubMed ID: 8861454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
    Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC
    J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
    Greene DA; Lattimer SA
    Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
    Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of cyclic AMP in the sciatic nerve of rats made diabetic with streptozotocin and the mechanism involved.
    Shindo H; Tawata M; Onaya T
    J Endocrinol; 1993 Mar; 136(3):431-8. PubMed ID: 7682591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
    Lu KM; Zhong XL; Zhu XX; Zhu QY
    Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
    Greene DA
    Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve.
    Sonobe M; Yasuda H; Hatanaka I; Terada M; Yamashita M; Kikkawa R; Shigeta Y
    Horm Metab Res; 1988 Nov; 20(11):717-8. PubMed ID: 3215630
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic effect of PGE1 analogue 01206.alpha CD on nerve Na(+)-K(+)-ATPase activity of rats with streptozocin-induced diabetes is mediated via cAMP: possible role of cAMP in diabetic neuropathy.
    Yasuda H; Maeda K; Sonobe M; Kawabata T; Terada M; Hisanaga T; Taniguchi Y; Kikkawa R; Shigeta Y
    Prostaglandins; 1994 May; 47(5):367-78. PubMed ID: 8066185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.
    Cotter MA; Dines KC; Cameron NE
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):534-40. PubMed ID: 7686634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
    Yasuda H; Sonobe M; Hisanaga T; Kawabata T; Maeda K; Kikkawa R; Shigeta Y
    Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.
    Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Stefani MR; Conner CE; Lattimer SA; Kamijo M; Greene DA; Sima AA
    Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.